# Vascular Closure Device Versus Transradial Approach in Primary Percutaneous Coronary Intervention

Study · id `cardio:ct-nct02831166` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02831166](<https://clinicaltrials.gov/study/NCT02831166>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT02831166

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease; Acute care and long-term living  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 250 participants.

## Technical summary

Registry record NCT02831166. Randomized; no masking; primary purpose treatment. Start 2016-01 (actual); primary completion 2019-10 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 250 participants (enrolled count; ClinicalTrials.gov record NCT02831166, source copy `cardio:ctgov-nct02831166-2020-02-11`, retrieved 2026-10-26)
- Started: 2016-01 (actual) (ClinicalTrials.gov record NCT02831166, source copy `cardio:ctgov-nct02831166-2020-02-11`, retrieved 2026-10-26)
- Primary completion: 2019-10 (actual) (ClinicalTrials.gov record NCT02831166, source copy `cardio:ctgov-nct02831166-2020-02-11`, retrieved 2026-10-26)
- Completion: 2019-11 (actual) (ClinicalTrials.gov record NCT02831166, source copy `cardio:ctgov-nct02831166-2020-02-11`, retrieved 2026-10-26)
- Countries: Brazil (ClinicalTrials.gov record NCT02831166, source copy `cardio:ctgov-nct02831166-2020-02-11`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02831166-2020-02-11`, retrieved 2026-10-26)

## The registry's words

- Brief title: Vascular Closure Device Versus Transradial Approach in Primary Percutaneous Coronary Intervention
- Acronym: ARISE-2
- Condition: Myocardial Infarction
- Condition: Complications; Device, Vascular
- Condition: Injury of Radial Artery
- Condition: Injury; Blood Vessel, Femoral, Artery
- Intervention (Procedure): Transradial primary percutaneous coronary intervention
- Intervention (Procedure): Transfemoral primary percutaneous coronary intervention
- Lead sponsor: Irmandade Santa Casa Misericórdia Marília
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Heart attack (myocardial infarction) (`cardio:myocardial-infarction`)

## Provenance

Content hash: d9a6dc1ca99c4c5e3ac5386eb5a7fefa5a23d2126c1d3a4f08ac0618db05562b
Last substantive edit: 2026-10-26
Evidence last checked: Not recorded
